Northeast Pharmaceutical Group Co., Ltd. (000597.SZ)
CNY 5.44
(0.18%)
CNY 5.44
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.16 Billion | 8.8 Billion | 8.14 Billion | 7.38 Billion | 8.22 Billion | 7.46 Billion |
| Cost of Revenue | 5.12 Billion | 5.37 Billion | 4.92 Billion | 4.49 Billion | 4.63 Billion | 4.37 Billion |
| Gross Profit | 3.03 Billion | 3.43 Billion | 3.21 Billion | 2.89 Billion | 3.58 Billion | 3.08 Billion |
| Operating Expenses | 2.77 Billion | 2.97 Billion | 2.85 Billion | 2.56 Billion | 3.13 Billion | 2.61 Billion |
| Selling, General and Administrative Expenses | 2.49 Billion | 2.31 Billion | 2.32 Billion | 2.04 Billion | 2.48 Billion | 2.06 Billion |
| Research and Development Expenses | 97.04 Million | 160.38 Million | 83.45 Million | 74.18 Million | 63.93 Million | 144.67 Million |
| Other Expenses | -50.27 Million | 498.23 Million | 452.33 Million | 442.04 Million | 584.88 Million | 137.77 Million |
| Cost and Expenses | 7.74 Billion | 8.35 Billion | 7.78 Billion | 7.05 Billion | 7.77 Billion | 6.99 Billion |
| Operating Income | 498.22 Million | 367.38 Million | 348.34 Million | 279.03 Million | 489.33 Million | 75.96 Million |
| Interest Expense | 133.21 Million | 92.11 Million | 120.15 Million | 120.86 Million | 125.58 Million | 154.62 Million |
| Income Tax Expense | 112.19 Million | 168.39 Million | 24.72 Million | 81.01 Million | 53.8 Million | 12.36 Million |
| Earnings before Tax | 488.17 Million | 525.44 Million | 120.16 Million | 91.83 Million | 224.24 Million | 213.73 Million |
| Net Income | 358.45 Million | 350.25 Million | 99.02 Million | 12.25 Million | 173.97 Million | 195.19 Million |
| Earnings Per Share Basic | 0.25 | 0.26 | 0.07 | 0.01 | 0.14 | 0.16 |
| Earnings Per Share Diluted | 0.25 | 0.26 | 0.07 | 0.01 | 0.14 | 0.16 |
| Weighted Average Shares Outstanding | 1.43 Billion | 1.34 Billion | 1.34 Billion | 1.22 Billion | 1.26 Billion | 1.2 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.43 Billion | 1.34 Billion | 1.34 Billion | 1.22 Billion | 1.26 Billion | 1.21 Billion |
| Gross Margin | 0.37 | 0.39 | 0.39 | 0.39 | 0.44 | 0.41 |
| EBIT Margin | 0.15 | 0.11 | 0.11 | 0.10 | 0.10 | 0.13 |
| Profit Margin | 0.04 | 0.04 | 0.01 | 0.00 | 0.02 | 0.03 |
| EBITDA | 1.19 Billion | 928.48 Million | 837.04 Million | 693.46 Million | 690.2 Million | 497.74 Million |
| Earnings Before Tax Margin | 0.06 | 0.04 | 0.04 | 0.04 | 0.06 | 0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.96 Billion | 2.22 Billion | 1.92 Billion | 8.16 Billion | 1.81 Billion | 1.89 Billion |
| Cost of Revenue | 1.32 Billion | 1.49 Billion | 1.19 Billion | 5.02 Billion | 1.14 Billion | 1.21 Billion |
| Gross Profit | 640.62 Million | 736.51 Million | 723.26 Million | 3.14 Billion | 670.38 Million | 685.53 Million |
| Operating Expenses | 549.78 Million | 564.35 Million | 645.34 Million | 2.77 Billion | 500.84 Million | 544.67 Million |
| Selling, General and Administrative Expenses | 821.44 Million | 352.18 Million | 590.63 Million | - | 393.86 Million | 802.02 Million |
| Research and Development Expenses | 17.44 Million | 18.94 Million | 17.03 Million | - | 52.15 Million | 17.27 Million |
| Other Expenses | -289.09 Million | 1.68 Million | -37.66 Million | -188.08 Million | -54.82 Million | -13.58 Million |
| Cost and Expenses | 1.87 Billion | 2.05 Billion | 1.84 Billion | 7.79 Billion | 1.64 Billion | 1.75 Billion |
| Operating Income | 58.06 Million | 160.63 Million | 77.92 Million | 366.37 Million | 169.53 Million | 123.17 Million |
| Interest Expense | 17.05 Million | 18.07 Million | 17.89 Million | 78.35 Million | 21.66 Million | 16.37 Million |
| Income Tax Expense | 17.12 Million | 55.21 Million | 56.65 Million | 112.19 Million | 43.02 Million | 19.95 Million |
| Earnings before Tax | 70.27 Million | 162.32 Million | 116.43 Million | 488.17 Million | 184.52 Million | 109.59 Million |
| Net Income | 51.15 Million | 99.17 Million | 57.63 Million | 358.45 Million | 138.67 Million | 84.89 Million |
| Earnings Per Share Basic | 0.04 | 0.07 | 0.04 | - | 0.10 | 0.06 |
| Earnings Per Share Diluted | 0.04 | 0.07 | 0.04 | - | 0.10 | 0.06 |
| Weighted Average Shares Outstanding | 1.42 Billion | 1.42 Billion | 1.42 Billion | 1.43 Billion | 1.42 Billion | 1.43 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.42 Billion | 1.42 Billion | 1.42 Billion | 1.43 Billion | 1.42 Billion | 1.43 Billion |
| Gross Margin | 0.33 | 0.33 | 0.38 | 0.38 | 0.37 | 0.36 |
| EBIT Margin | 0.04 | 0.10 | 0.09 | - | 0.17 | 0.07 |
| Profit Margin | 0.03 | 0.04 | 0.03 | 0.04 | 0.08 | 0.04 |
| EBITDA | 87.33 Million | 212.23 Million | 171.73 Million | - | 309.25 Million | 136.5 Million |
| Earnings Before Tax Margin | 0.03 | 0.07 | 0.04 | 0.04 | 0.09 | 0.06 |
3147
M3M
ESLT
BYFC
BPCL
FHN-PF